Oncofactor Corp: US-based developer of innovative cancer therapeutics disrupting tumor-immune signaling.

US-based NĒRx BioSciences Inc, founded in 2009, specializes in discovering and developing targeted cancer therapeutics.

Rafael Holdings, Inc.: A US-based holding company specializing in real estate development and cancer therapeutics.

OncoFusion Therapeutics Inc.: Personalized cancer therapeutics developer, specializing in genetic inhibitors.

ENB Therapeutics, Inc.: A US-based biopharmaceutical firm developing novel inhibitors to treat cancers.

Y CombinatorW15

Shasqi: Innovating cancer treatment with click chemistry for targeted therapy.

Precision Therapeutics, Inc. develops cancer treatments and provides personalized tumor profiling in the US.

Jivana Biotechnology, a preclinical-stage firm, develops gene silencing cancer therapeutics.

Culver City-based TORL-Bio, advancing novel antibody-based cancer therapeutics since 2018.

Bolt Biotherapeutics: A biotech firm developing immune-stimulating cancer therapeutics, traded publicly in the US.

US-based Ribon, a clinical-stage biotech firm, pioneers first-in-class inhibitors to combat cancer cell survival.

Innovative cancer therapeutics company developing affordable, dual-action treatments for enhanced efficacy and reduced toxicity.

Modifi Biosciences: Pioneering DNA modification for innovative cancer therapeutics.

KayoThera, a biotech firm, pioneers first-in-class therapeutics for advanced and metastatic cancers.

SynerGene Therapeutics: A biopharmaceutical firm innovating nanotech cancer treatments.

Exovita Biosciences, a biotech firm, pioneers in developing exosome-based cancer therapeutics.

San Diego-based MEI Pharma, Inc. develops novel oncology therapeutics targeting cancer metabolism for enhanced tumor cell inhibition.

Venture-backed Iterion Therapeutics develops targeted cancer therapeutics, leading with Tegavivint.

Da Zen Theranostics: Innovating cancer diagnostics and therapy with targeted, visibility-enhancing products, based in San Jose, CA.

Paramita Therapeutics: An innovative biotech startup developing water-soluble therapies for cancer and infectious diseases.

Sutro Biopharma, a California-based medical firm, develops and manufactures cancer therapy drugs.

US-based Immunitas advances immuno-oncology therapeutics through an integrated genomics platform.

Curamir, a biotech firm, innovates miRNA-based cancer therapeutics to combat chemoresistance and enhance delivery.

US-based Xcovery develops low-toxicity, oral cancer therapeutics for improved patient care.

Y CombinatorW24

Developing HAPs to target solid tumors with reduced toxicity.